| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 172,942 | 165,198 | 124,660 | | Cost of Revenue | 105,100 | 92,847 | 68,031 | | | Gross Profit | 67,842 | 72,351 | 56,629 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 57,864 | 52,972 | 42,478 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 9,978 | 19,379 | 14,151 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,888 | 3,249 | 1,209 | | Earnings Before Interest And Taxes | 12,866 | 22,628 | 15,360 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 12,866 | 22,628 | 15,360 | | Income Tax Expense | 809 | 4,857 | (3,630) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,057 | 17,771 | 18,990 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 12,057 | 17,771 | 18,990 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,057 | $17,771 | $18,990 |
|
0.22% Nasdaq 
Income Statement
